Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome

Clinical trial NCT01332305 · COMPLETED

Trial details

NCT number: NCT01332305
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2007-01-01
Primary completion: 2008-01-01
Enrollment: 217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.